-
A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia.
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.
The leukaemic cells of more than 90% of chronic myelogenous leukaemia (CML) patients and of 10% of acute lymphocytic leukaemia (ALL) patients carry the t(9:22) (q34:q11) translocation which generates the Philadelphia chromosome (Ph1). In CML the abl gene is translocated from chromosome 9 to the centre of the bcr gene on chromosome 22 and this results in production of chimaeric bcr-abl RNA translated into a protein of relative molecular mass (Mr) 210,000 (210K). Our data indicate that in ALL abl is translocated into the 5' region of the bcr gene. The consequence of this is the expression of a fused transcript in which the first exon of bcr is linked to the second abl exon. This transcript encodes a 190K protein kinase.
PMID: 2825022 [PubMed - indexed for MEDLINE]
-
Cited by 19 PubMed Central articles
-
Molecular separation of two signaling pathways for the receptor, Notch.
Le Gall M, De Mattei C, Giniger E.
Dev Biol. 2008 Jan 15; 313(2):556-67. Epub 2007 Dec 11.
[Dev Biol. 2008]
-
Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
Mundhada S, Luthra R, Cano P.
BMC Cancer. 2004 Jun 17; 4:25. Epub 2004 Jun 17.
[BMC Cancer. 2004]
-
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.
Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA.
J Exp Med. 1999 May 3; 189(9):1399-412.
[J Exp Med. 1999]
- » See all...